David is a founding partner of Brandon Capital Partners.
Prior to co-founding Brandon Capital Partners, David established Brandon Capital Management, the Investment Manager for three life sciences Pooled Development Funds. Before this, he was the foundation CEO of Peptech during its transition from start-up to global R&D and manufacturing operations in Australia, the UK, the US and Denmark. Earlier, David worked with Pharmacia AB (now part of Pfizer), including five years at their head office in Sweden.
David was the former CEO of GI Therapies. He is currently a Director of Nanosonics.
David has a Bachelor of Rural Science (Honours) from the University of New England, a PhD in Chemical Engineering from the University of Sydney and a Masters degree in Applied Finance and Investments from the Financial Services Institute of Australasia.